Disease outbreaks and other matters of airline medical interest
Further to the WHO announcement (see last update) on COVID-19, the IATA response to the end to the PHEIC status is here: https://www.iata.org/en/pressroom/2023-releases/2023-05-06-01/ Also, here is the commentary in Nature: https://www.nature.com/articles/d41586-023-01559-z
Current trends with COVID are the usual mixed picture, as illustrated by rates continuing to decline in India, but trebled over the past month in China (both trends probably related to XBB.1.16 which is now at 10% of new sequences globally) and rising in Indonesia.
As the pandemic transitions to something that has been termed a “permademic” (an extended health threat before it settles into “background” or endemic), the threat of highly pathogenic avian flu (H5N1) is on the horizon at an unknown distance.
An analysis by BlueDot assesses the overall risk to humans as low but increasing. It points to an exponential increase in wild birds rather than domestic poultry and a series of “unusual mortality events” amongst mammals since 2022 (in USA, Spain and Peru), with genetic adaptations for mammals. It notes that CDC assesses the current H5N1 vaccine candidate, and existing antivirals, as likely to provide good protection/efficacy. (Source: BlueDot).